BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for NOVUS THERAPEUTICS INC (NVUS)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for NOVUS THERAPEUTICS INC:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-02-16
4:17 pm
Sale		 2020-12-31 13G NOVUS THERAPEUTICS INC
NVUS		 BIOTECHNOLOGY VALUE FUND L P 1,503,121
9.990%		 -14,918decrease
(-0.98%)		 Filing
2020-12-30
5:27 pm
Purchase		 2020-12-28 13G NOVUS THERAPEUTICS INC
NVUS		 BIOTECHNOLOGY VALUE FUND L P 1,518,039
10.000%		 3,520increase
(+0.23%)		 Filing
2020-12-28
5:13 pm
Purchase		 2020-12-22 13G NOVUS THERAPEUTICS INC
NVUS		 BIOTECHNOLOGY VALUE FUND L P 1,514,519
9.990%		 1,319,193increase
(+675.38%)		 Filing
2020-10-05
5:26 pm
Purchase		 2020-10-01 13G NOVUS THERAPEUTICS INC
NVUS		 BIOTECHNOLOGY VALUE FUND L P 195,326
15.600%		 195,326increase
(New Position)		 Filing